ICUI

ICU Medical, Inc. NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · icumed.com

$118.67

Mkt Cap $3.0B

52w Low $107.00 21.9% of range 52w High $160.29

50d MA $130.87 200d MA $133.67

P/E (TTM) 4001.7x

EV/EBITDA 14.1x

P/B 1.4x

Debt/Equity 0.7x

ROE 0.0%

P/FCF 38.3x

RSI (14) —

ATR (14) —

Beta 0.85

50d MA $130.87

200d MA $133.67

Avg Volume 291.2K

About

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors;… ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 19, 2026	AMC	1.68	1.91	+13.7%	149.74	+0.3%	+4.9%	+1.2%	+1.8%	+3.6%	+0.7%	—
Nov 6, 2025	AMC	1.43	2.03	+42.0%	129.67	+12.3%	+8.1%	+7.4%	+10.4%	+7.3%	+6.8%	—
Aug 7, 2025	AMC	1.44	2.10	+45.8%	129.91	-4.0%	-13.1%	-16.8%	-15.1%	-12.1%	-13.9%	—
May 8, 2025	AMC	1.23	1.72	+39.8%	142.87	-5.3%	-3.2%	+1.0%	+0.5%	-4.9%	-1.6%	—
Feb 27, 2025	AMC	1.48	2.11	+42.6%	149.75	-4.8%	-2.3%	-5.5%	-5.9%	-4.1%	-5.0%	—
Nov 12, 2024	AMC	1.25	1.59	+27.2%	178.01	+8.6%	-1.8%	-3.4%	-5.7%	-4.5%	-4.7%	—
Aug 7, 2024	AMC	0.98	1.56	+59.2%	121.79	+17.8%	+24.3%	+25.4%	+21.6%	+23.2%	+21.5%	—
May 7, 2024	AMC	0.84	0.96	+14.3%	101.77	-3.4%	-1.1%	+4.5%	+5.2%	+6.5%	+3.4%	—
Feb 27, 2024	AMC	1.18	1.57	+33.1%	106.81	+5.0%	+5.3%	+2.3%	-1.3%	+0.1%	-4.0%	—
Nov 6, 2023	AMC	1.29	1.57	+21.7%	102.00	-0.6%	-17.3%	-15.0%	-20.5%	-19.7%	-19.6%	—
Aug 7, 2023	AMC	1.55	1.88	+21.3%	171.44	-10.5%	-16.6%	-17.0%	-17.2%	-16.9%	-16.7%	—
May 8, 2023	AMC	1.38	1.74	+26.1%	184.04	+4.7%	+13.6%	+13.0%	+9.8%	+9.1%	+8.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 27	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$124.82	$123.95	-0.7%	-1.6%	-3.1%	-7.5%	-4.5%	-4.8%
Apr 17	Piper Sandler	Maintains	Overweight → Overweight	—	$126.04	$128.33	+1.8%	+3.1%	+3.6%	+1.7%	+1.0%	-1.2%
Feb 20	Piper Sandler	Maintains	Overweight → Overweight	—	$149.74	$150.21	+0.3%	+4.9%	+1.2%	+1.8%	+3.6%	+0.7%
Feb 20	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$149.74	$150.21	+0.3%	+4.9%	+1.2%	+1.8%	+3.6%	+0.7%
Nov 7	Piper Sandler	Maintains	Overweight → Overweight	—	$129.67	$145.60	+12.3%	+8.1%	+7.4%	+10.4%	+7.3%	+6.8%
Nov 7	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$129.67	$145.60	+12.3%	+8.1%	+7.4%	+10.4%	+7.3%	+6.8%
Oct 21	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$117.34	$117.41	+0.1%	+3.1%	+4.3%	+3.7%	+5.2%	+4.7%
Sep 10	Piper Sandler	Maintains	Overweight → Overweight	—	$130.57	$131.65	+0.8%	+2.3%	+3.4%	-0.1%	+1.2%	-0.2%
Aug 8	Raymond James	Maintains	Strong Buy → Strong Buy	—	$129.91	$124.71	-4.0%	-13.1%	-16.8%	-15.1%	-12.1%	-13.9%
May 9	Raymond James	Maintains	Strong Buy → Strong Buy	—	$142.87	$135.35	-5.3%	-3.2%	+1.0%	+0.5%	-4.9%	-1.6%
Apr 21	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$138.67	$137.06	-1.2%	-1.4%	-5.8%	-4.6%	-1.1%	-2.2%
Apr 8	Needham	Maintains	Hold → Hold	—	$142.25	$147.54	+3.7%	-5.8%	+6.2%	-2.7%	+0.3%	-1.2%
Dec 11	Jefferies	Upgrade	Hold → Buy	—	$160.11	$167.49	+4.6%	+3.8%	+3.4%	+1.0%	-0.7%	-1.8%
Nov 13	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$178.01	$193.30	+8.6%	-1.8%	-3.4%	-5.7%	-4.5%	-4.7%
Oct 15	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$180.30	$180.73	+0.2%	-0.4%	+2.0%	+0.1%	+0.4%	-0.8%
Sep 12	Raymond James	Maintains	Outperform → Outperform	—	$170.42	$172.15	+1.0%	+2.2%	+5.0%	+5.3%	+3.4%	+3.4%
Aug 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$121.79	$143.48	+17.8%	+24.3%	+25.4%	+21.6%	+23.2%	+21.5%
Aug 8	Raymond James	Maintains	Outperform → Outperform	—	$121.79	$143.48	+17.8%	+24.3%	+25.4%	+21.6%	+23.2%	+21.5%
Jun 17	Raymond James	Upgrade	Market Perform → Outperform	—	$113.61	$116.80	+2.8%	+4.3%	+5.3%	+6.1%	+2.2%	+2.5%
Feb 28	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$106.81	$112.15	+5.0%	+5.3%	+2.3%	-1.3%	+0.1%	-4.0%
May 9	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$184.04	$192.74	+4.7%	+13.6%	+13.0%	+9.8%	+9.1%	+8.2%
Nov 8	Raymond James	Downgrade	Outperform → Market Perform	—	$142.07	$128.90	-9.3%	+2.4%	+2.1%	+10.3%	+16.5%	+11.7%
Aug 9	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$188.10	$170.00	-9.6%	-11.6%	-8.9%	-9.9%	-9.0%	-6.6%
Aug 9	Raymond James	Maintains	Outperform → Outperform	—	$188.10	$170.00	-9.6%	-11.6%	-8.9%	-9.9%	-9.0%	-6.6%
Aug 8	Raymond James	Maintains	Outperform → Outperform	—	$179.63	$179.12	-0.3%	+4.7%	-7.4%	-4.6%	-5.7%	-4.7%
Aug 3	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$179.27	$179.30	+0.0%	-0.8%	-2.0%	+0.2%	+4.9%	-7.2%
May 10	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$201.17	$187.48	-6.8%	-8.2%	-13.8%	-13.2%	-12.9%	-10.2%
May 10	Raymond James	Maintains	Outperform → Outperform	—	$201.17	$187.48	-6.8%	-8.2%	-13.8%	-13.2%	-12.9%	-10.2%
Feb 28	Raymond James	Maintains	Outperform → Outperform	—	$228.95	$227.04	-0.8%	+3.4%	+3.0%	+3.0%	+4.9%	+6.1%
Oct 22	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$230.50	$227.79	-1.2%	-2.0%	-2.4%	-2.7%	-1.3%	-0.1%
Sep 9	Raymond James	Maintains	Outperform → Outperform	—	$260.00	$259.93	-0.0%	-3.0%	-6.1%	-7.7%	-8.0%	-6.2%
Sep 9	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$260.00	$259.93	-0.0%	-3.0%	-6.1%	-7.7%	-8.0%	-6.2%
Aug 6	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$192.47	$191.41	-0.6%	+0.4%	+0.5%	-0.8%	-2.0%	-2.9%
Aug 5	Raymond James	Maintains	Outperform → Outperform	—	$190.73	$183.39	-3.8%	+0.9%	+1.3%	+1.5%	+0.1%	-1.1%
Feb 26	Raymond James	Maintains	Outperform → Outperform	—	$218.19	$218.19	+0.0%	-4.9%	-4.9%	-6.2%	-7.0%	-9.2%
Feb 11	Raymond James	Maintains	Outperform → Outperform	—	$212.78	$214.07	+0.6%	+2.4%	+3.6%	+2.9%	+3.0%	+2.1%
Jan 8	KeyBanc	Maintains	Overweight → Overweight	—	$219.99	$219.96	-0.0%	+0.7%	+1.2%	-1.1%	+0.9%	+0.6%
Nov 6	KeyBanc	Maintains	Overweight → Overweight	—	$188.29	$195.00	+3.6%	-0.0%	+1.6%	+4.2%	+3.6%	+3.6%
Nov 6	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$188.29	$195.00	+3.6%	-0.0%	+1.6%	+4.2%	+3.6%	+3.6%
Sep 2	KeyBanc	Maintains	Overweight → Overweight	—	$197.98	$202.65	+2.4%	+0.7%	-2.6%	-5.4%	-6.0%	-1.4%
Sep 2	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$197.98	$202.65	+2.4%	+0.7%	-2.6%	-5.4%	-6.0%	-1.4%
Aug 11	Raymond James	Maintains	Outperform → Outperform	—	$178.88	$197.21	+10.2%	+8.1%	+5.7%	+5.6%	+4.3%	+3.1%
May 13	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$187.36	$187.00	-0.2%	-2.9%	-1.0%	-0.7%	-0.4%	+0.8%
May 13	KeyBanc	Maintains	Overweight → Overweight	—	$187.36	$187.00	-0.2%	-2.9%	-1.0%	-0.7%	-0.4%	+0.8%
May 8	Raymond James	Maintains	Outperform → Outperform	—	$217.36	$211.55	-2.7%	-8.9%	-7.7%	-13.8%	-16.3%	-14.7%
Mar 18	KeyBanc Capital Markets	Upgrade	Sector Weight → Overweight	—	$176.87	$175.78	-0.6%	+3.8%	+1.1%	-2.2%	-8.1%	+3.0%
Mar 18	KeyBanc	Upgrade	Sector Weight → Overweight	—	$176.87	$175.78	-0.6%	+3.8%	+1.1%	-2.2%	-8.1%	+3.0%
Feb 28	Raymond James	Maintains	Outperform → Outperform	—	$200.35	$194.10	-3.1%	-2.3%	+0.2%	-2.9%	-1.0%	-4.3%
Aug 8	Raymond James	Downgrade	Strong Buy → Outperform	—	$245.67	$169.00	-31.2%	-33.3%	-32.1%	-31.1%	-31.6%	-33.0%
Mar 1	Raymond James	Maintains	Strong Buy → Strong Buy	—	$245.76	$247.65	+0.8%	+2.7%	-3.9%	-4.7%	-6.0%	-5.5%

Recent Filings

8-K · 5.02 !!! Very High

ICU Medical Inc -- 8-K 5.02: Executive Change

ICU Medical's Compensation Committee amended its Executive Severance Plan, potentially affecting executive retention and cost structures, though specific changes and financial impact details require full filing review.

Feb 20

8-K

ICU Medical Inc -- 8-K Filing

ICU Medical improved its gross margin to 38% in Q4 2025 from 36% year-over-year, indicating better operational efficiency and pricing power that should enhance profitability.

Feb 19

Data updated apr 25, 2026 2:55pm · Source: massive.com